Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1229]

ASCO 2022: Nimotuzumab significantly improves overall survival for K-Ras wild-type advanced pancreatic cancer

ASCO 2022: Nimotuzumab significantly improves overall survival for K-Ras wild-type advanced pancreatic cancer

ASCO 2022: Follow-up data further support the superior efficacy of cabozantinib in patients with progressive differentiated thyroid cancer

ASCO 2022: Follow-up data further support the superior efficacy of cabozantinib in patients with progressive...

Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA

Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and...

ECOG-ACRIN research highlights at ASCO 2022

ECOG-ACRIN research highlights at ASCO 2022

ASCO 2022: Acupuncture improves chronic radiation-induced dry mouth for patients with head and neck cancer

ASCO 2022: Acupuncture improves chronic radiation-induced dry mouth for patients with head and neck cancer

ASCO 2022: Desmoplastic melanoma responds to PD-1 blockade immunotherapy

ASCO 2022: Desmoplastic melanoma responds to PD-1 blockade immunotherapy

Study reveals imaging approach with potential to detect lung cancer earlier, at the cellular level

Study reveals imaging approach with potential to detect lung cancer earlier, at the cellular level

Gene mutations that contribute to head and neck cancer also provide “precision” treatment targets

Gene mutations that contribute to head and neck cancer also provide “precision” treatment targets

Could blocking or deleting a protein help prevent common oral cancers?

Could blocking or deleting a protein help prevent common oral cancers?

An international consortium reports the discovery of MCLA-158, the first clinical candidate screened in organoids targeting cancer stem cells of solid tumors

An international consortium reports the discovery of MCLA-158, the first clinical candidate screened in organoids...

More from ecancer